Regeneron, and the pugnacious pair who run it, take center stage

Regeneron, and the pugnacious pair who run it, take center stage

STAT Plus: Trump’s treatment puts a spotlight on Regeneron, and the pugnacious pair who run it

By MATTHEW HERPER

HYACINTH EMPINADO/STAT

President Trump's treatment with the company's experimental Covid-19 antibody drug has raised Regeneron's profile — and stirred criticism.

READ MORE